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Very Long-chain Fatty Acid-containing Lipids rather than
Sphingolipids per se Are Required for Raft Association and
Stable Surface Transport of Newly Synthesized Plasma
Membrane ATPase in Yeast*
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From the Division of Biochemistry, University of Fribourg, CH-1700 Fribourg, Switzerland
The proton-pumping H-ATPase, Pma1p, is an abundant
and very long lived polytopic protein of the yeast plasma mem-
brane. Pma1p constitutes a major cargo of the secretory path-
way and thus serves as a model to study plasma membrane bio-
genesis. Pma1p associates with detergent-resistant membrane
domains (lipid “rafts”) already in the ER, and a lack of raft asso-
ciation correlates with mistargeting of the protein to the vacuole,
where it is degraded.We are analyzing the role of specific lipids
inmembrane domain formation andhave previously shown that
surface transport of Pma1p is independent of newly synthesized
sterols but that sphingolipidswithC26 very long chain fatty acid
are crucial for raft association and surface transport of Pma1p
(Gaigg, B., Timischl, B., Corbino, L., and Schneiter, R. (2005)
J. Biol. Chem. 280, 22515–22522). We now describe a more
detailed analysis of the function that sphingolipids play in this
process. Using a yeast strain in which the essential function of
sphingolipids is substituted by glycerophospholipids containing
C26 very long chain fatty acids, we find that sphingolipids per se
are dispensable for raft association and surface delivery of
Pma1p but that the C26 fatty acid is crucial. We thus conclude
that the essential function of sphingolipids for membrane
domain formation and stable surface delivery of Pma1p is pro-
vided by theC26 fatty acid that forms part of the yeast ceramide.
Integral membrane proteins enter the membrane environ-
ment in the ER2 and are then transported along a vesicular
pathway to their final subcellular destination (1). Although
much attention has been paid to uncovering the role of protein-
encoded signals in determining sorting of the membrane-
bound cargo to its final destination, comparatively little is
known about how the lipid-protein interface itself affects pro-
tein sorting. The integrity of this interface is probably surveilled
by components of the protein quality control system to ensure
that only functional proteins are delivered to the cell surface
when needed. Co-delivery of integral membrane proteins
together with their surrounding membrane domain to the cell
surface may, in principle, ensure balanced expansion of the
plasma membrane itself.
The proton-pumping H-ATPase, Pma1p, is biosyntheti-
cally inserted into the ERmembrane, where it homo-oligomer-
izes to form a 1.8-MDa complex that resists detergent extrac-
tion (2). This complex is then packaged into a larger subclass of
COPII transport vesicles that contain Lst1p in addition to
Sec24p (3) and is transported to the cell surface by a branch of
the secretory pathway that does not intersect with endosomes
(4, 5). Once at surface, Pma1p becomes stabilized and occupies
domains that are distinct from those occupied by the argi-
nine/H symporter Can1p (6).
A relationship between Pma1p biogenesis and lipid synthesis
is indicated by the observations that long-chain base or cera-
mide synthesis is required for oligomerization and raft associ-
ation of Pma1p in the ER (2, 7). Oligomerization of Pma1p,
however, is not required for ER export or surface delivery but
might be important for stabilization of the protein at the cell
surface (2, 7). Raft association of Pma1p, on the other hand, is
required for surface delivery and subsequent stabilization of the
protein (7–9).
We previously observed that newly synthesized Pma1p is
mistargeted to the vacuole in an elo3mutant that affects acyl
chain elongation and hence the synthesis of the ceramide-
bound C26 very long-chain fatty acid (10). Further character-
ization of the role of lipids in Pma1p biogenesis revealed that
neither sterols nor the head group modifications on the sphin-
golipids are important for raft association and surface transport
of Pma1p (11). Instead, the results suggested that ceramide lev-
els and/or their substitution with saturated very long-chain
fatty acids are crucial for the biogenesis of Pma1p. These results
also indicated that the lipid requirement of Pma1p to form
membrane microdomains is distinct from the classical sterol
and sphingolipid-rich domains that are normally referred to as
detergent-resistant membranes/lipid rafts (12–14).
The aim of this study is to discriminate between the role of
ceramide and that of the very long-chain fatty acid in Pma1p
sorting. Such discrimination is made possible by the use of a
mutant that bypasses the essential requirement for sphingolip-
ids by producing unusual inositol-containing glycerophospho-
lipids carrying aC26 fatty acid in the sn-2 position (15). Surpris-
ingly, Pma1p is raft-associated and stably transported to the cell
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surface if sphingolipids are replaced by C26-containing glyc-
erophospholipids. Reduction of the length of the acyl chain on
the suppressor lipids, however, impairs the essential function of
these lipids and results in conditional degradation of Pma1p,
strongly indicating that lipidswith aC26 fatty acid either bound
to a glycerophospholipid or to ceramide are crucial for the vital
function of sphingolipids and for surface delivery and stability
of Pma1p. These observations are discussed in the context of a
possible hydrophobic match between the length of a protein
transmembrane domain and the thickness of its surrounding
lipid membrane as a parameter that may affect Pma1p sorting
to or retention at the plasma membrane of yeast.
EXPERIMENTAL PROCEDURES
Yeast Strains and Growth Conditions—Yeast strains used in
this study are listed in Table 1. Strains bearing single deletions
of nonessential genes were obtained from EUROSCARF (avail-
able on the World Wide Web at www.rz.uni-frankfurt.de/FB/
fb16/mikro/euroscarf/index.html) (16). Strains were cultivated
at 24, 30, or 37 °C in YPD-richmedium (1% Bacto yeast extract,
2% Bacto peptone (USBiological, Swampscott, MA), 2% glu-
cose) or in minimal medium. Cells lacking sphingolipids were
cultivated in complete synthetic medium or complete complex
mediumas described (17). Phytosphingosine (PHS)was supple-
mented in 0.5% Tergitol at a concentration of 25 M. The pres-
ence of the kanMXmarker was selected for by growing the cells
on medium containing 200 g/ml G418 (Invitrogen). Chemi-
cals were purchased from Sigma, unless otherwise noted.
Aureobasidin A was obtained from Takara Bio Inc. (Shiga,
Japan); myriocin and fumonisin B1 were from Alexis Corp.
(Lausen, Switzerland).
For DNA cloning and propagation of plasmids, Escherichia
coli strain XL1-blue (Stratagene, La Jolla, CA) was used. To
generate double mutants with pep4, a pep4::LEU2 disruption
cassette (pTS17; Tom Stevens, University of Oregon, Eugene,
OR) was cut with BamHI and used for transformation. PEP4
disruption was confirmed by PCR and a plate assay for car-
boxypeptidase Y activity.
The plasmid containing a GFP-tagged version of Pma1p was
kindly provided by A. Breton (Institut de Biochimie et Genet-
ique Cellulaires, Bordeaux, France) (18). The URA3marker on
this plasmid was switched to LEU2 using themarker swap plas-
mid pUL9 (19).
Isolation of Detergent-insoluble Membrane Domains—De-
tergent-insoluble membrane domains were isolated after flota-
tion on Optiprep gradients (Axis-Shield, Huntingdon, UK) as
previously described (10, 20). Proteins were precipitated with
trichloroacetic acid (10%), dissolved in sample buffer, and sub-
jected to SDS-PAGE and Western blot analyses using rabbit
antibodies against Pma1p (1:10,000), Gas1p (1:2000; a kind gift
from A. Conzelmann, University Fribourg, Switzerland), and
Wbp1p (1:1000; a kind gift from C. Jakob and M. Aebi, ETH
Zurich, Switzerland).
Pulse-Chase Analysis—For pulse-chase analysis, cells were
grown to A600 nm1 in minimal medium lacking cysteine and
methionine, unless otherwise noted, and the culture was then
split and preincubated at either 24 or 37 °C for 15 min. Cells
were pulsed with 100 Ci/ml EXPRE35S35S protein labeling
mix (1175 Ci/mmol; PerkinElmer Life Sciences) for 5 min.
Chase was initiated by the addition of chase solution (100;
0.3% cysteine, 0.3% methionine, 300 mM ammonium sulfate).
At each time point, cells were removed (1 A600 nm unit), placed
on ice, and arrested with 20 mM NaN3/NaF. Cells were centri-
fuged; resuspended in 50 mM Tris-HCl, pH 7.5, 5 mM EDTA,
10 g/ml leupeptin A, 10 g/ml pepstatin; and disrupted by
vortexing with glass beads. SDS was added to 1%, and the
lysate was incubated at 45 °C for 10 min. The lysate was
diluted by the addition of 800 l of TNET (30 mM Tris-HCl,
pH 7.5, 120 mM NaCl, 5 mM EDTA, 1% Triton X-100) and
centrifuged at 15,000  g for 10 min. The supernatant was
incubated with anti-Pma1p antibody and protein A-Sepha-
rose. Immunoprecipitates were analyzed by SDS-PAGE,
visualized with a PhosphorImager, and quantified using
Quantify One software (Bio-Rad).
Detergent resistance of newly synthesized Pma1p was exam-
ined as previously described (9–11). Lysates of labeled cells
(3–4A600 nm equivalents) were extractedwith 1%TritonX-100
for 30 min at 4 °C. Samples were centrifuged at 100,000 g for
1 h. Pellets were resuspended in 1% SDS. Detergent concentra-
tions in aliquots of total, supernatant, and pellet samples were
adjusted for immunoprecipitation.
Fluorescence Microscopy—in vivo localization of green fluo-
rescent protein (GFP)-taggedPma1pwas performedby fluores-
cence microscopy using a Zeiss Axioplan 2 microscope (Carl
Zeiss, Oberkochen, Germany) equipped with an AxioCam
CCD camera and AxioVision 3.1 software. Lucifer yellow
uptake was examined as described (21).
Lipid Analysis—For sphingolipid analysis, 10A600 nm units of
cells (1 108 cells) grown in SC-inositol were harvested, resus-
pended in 1 ml of fresh SC-inositol, and labeled by the addition
of 40 Ci of [3H]inositol (1 mCi/ml; American Radiolabeled
Chemicals Inc., St. Louis,MO). Cells were incubated for 40min
at 30 °C, diluted with prewarmed fresh medium, and incubated
TABLE 1
S. cerevisiae strains used in this study
Strain Relevant genotype Source or reference
YRS1878 MATa ura3-52 leu2-3,112 ade1 22
YRS1877 MATa ura3-52 leu2-3,112 ade1 lcb1::URA3 SLC1-1 22
YRS1029 MATa ura3 leu2 his4 bar1 end8-1 49
YRS1118 MAT his3200 leu21 ura3-52 elo3::his5 10
YRS2915 MATa ura3-52 leu2-3,112 ade1 pep4::LEU2 This work
YRS2138 MATa ura3-52 leu2-3,112 ade1 lcb1::URA3 SLC1-1 pep4::LEU2 This work
YRS2569 MATa ura3-52 leu2-3,112 ade1 pPMA-GFP-URA3 This work
YRS2942 MATa ura3-52 leu2-3,112 ade1 lcb1::URA3 SLC1-1 pPMA1-GFP-LEU2 This work
YRS2914 MATa ura3-52 leu2-3,112 ade1 lcb1::URA3 SLC1–1 elo3::kanMX4 This work
YRS2943 MATa ura3-52 leu2-3,112 ade1 lcb1::URA3 SLC1–1 elo3::kanMX4 pPMA1-GFP-LEU2 This work
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for another 80min. Labelingwas terminated by addingNaF and
NaN3 to a final concentration of 20 mM. Cells were harvested
and broken with glass beads, and lipids were extracted with
chloroform/methanol (1:1; v/v). Phospholipidswere deacylated
by treatment with mild base, and sphingolipids were analyzed
by thin layer chromatography on silica gel 60 plates (Merck)
using chloroform, methanol, 0.25% KCl (55:45:5; v/v/v) as the
solvent system. Radioactivity was detected and quantified by
two-dimensional radioscanning on a Berthold Tracemaster 40,
and plates were visualized using a PhosphorImager (Bio-Rad).
For lipid analysis by mass spectrometry, 40,000 gmicroso-
mal membranes were extracted three times with ethanol/wa-
ter/diethylether/pyridine/NH4OH (15:15:5:1:0.018; v/v/v/v/v)
at 60 °C, for 15 min each. Lipids were resuspended in chloro-
form/methanol (1:1; v/v) and analyzed in the negative ionmode
on aBruker EsquireHCT ion trapmass spectrometer (ESI)with
a flow rate of 120 l/h and a capillary tension of 250 V. Ion
fragmentationwas inducedwith argon as collision gas at a pres-
sure of 8 millibars.
RESULTS
Characterization of the SLC1-1 Suppressor Strain—Sphingo-
lipids or intermediates of the sphingolipid biosynthetic path-
way are essential lipids in yeast, as indicated by the fact that
long-chain base synthesis mediated by serine palmitoyltrans-
ferase (LCB1,2) is vital (22, 23). However, the essential require-
ment for long-chain base synthesis is bypassed in a suppressor
strain that produces novel C26 fatty acid-containing inositol
glycerophospholipids that structurally mimic sphingolipids
(Fig. 1) (15). The semidominant SLC1-1 mutation results in a
Q44L substitution in Slc1p, an 1-acyl-sn-glycerol-3-phosphate
acyltransferase (24). The semidominant mutation is thus
thought to confer altered substrate specificity to Slc1-1p, ena-
bling the transfer of C26 to the sn-2 position of glycerophos-
pholipids (24).
To determine the relative fitness of the SLC1-1 suppressor
strain, we first analyzed its growth and viability in the presence
or absence of exogenous phytosphingosine (PHS) as a long-
chain base that restores sphingolipid synthesis in this strain
(Fig. 2, A and B). This analysis revealed that the SLC1-1 strain
grew more slowly than a corresponding wild-type strain but
that the strain remained fully viable even in the absence of PHS.
PHS itself did not appear to significantly improve growth of the
suppressor strain but inhibited growth of both SLC1-1 and
wild-type cells. Labeling of cells with [3H]inositol confirmed
the absence of sphingolipids, since there were no detectable
mild base-resistant lipids present in SLC1-1 when grown with-
out PHS. The addition of PHS, however, restored sphingolipid
synthesis in the suppressor strain (Fig. 2C).
The presence of C26-containing inositol gylcerophospholip-
ids in SLC1-1 was furthermore confirmed by mass spectrome-
try, which revealed twomajor C26-containing inositol glycero-
phospholipid species in SLC1-1 that were not detectable in
wild-type cells (Fig. 2D). Presence of the C26 fatty acid in these
two lipid species was confirmed by collision induced fragmen-
tation, which yielded an ion of m/z 395, characteristic for C26
(Fig. 2E).
Taken together, these results indicate that the SLC1-1 strain
is viable in the absence of sphingolipids and that the strain
synthesizes C26-containing inositol glycerophospholipids,
consistent with the original characterization of the lipids made
by the suppressor strain (15).
Association of Pma1p and Gas1p with Detergent-resistant
Membranes in the Absence of Sphingolipids—We next exam-
ined whether the association of plasma membrane proteins
with detergent-resistant membranes was affected by the
absence of sphingolipids in SLC1-1. The glycosylphosphatidyl-
inositol-anchored Gas1p and the polytopic proton-pumping
ATPase Pma1p are two yeast plasma membrane proteins that
associate with detergent-resistant membranes (20). Steady-
state association of these two proteins with detergent-resistant
membranes depends on sphingolipids and sterols (20). To
examine raft association of Gas1p and Pma1p in cells lacking
sphingolipids, membranes were prepared from wild-type and
SLC1-1 cells that were grown in the presence or absence of
PHS. These membranes were then extracted with detergent
and floated in an Optiprep density gradient to separate deter-
gent-resistant membranes in the top fractions of the gradient
from the solubilized material. This analysis revealed that
Pma1p and Gas1p were both enriched in the detergent-resis-
FIGURE 1. Structural comparison of sphingolipids and C26-containing
inositol glycerophospholipids made in the SLC1-1 strain. A, structure
of a yeast sphingolipid, inositolphosphorylceramide, containing ceramide
with an amide-linked C26 very long-chain fatty acid. B, structure of a sup-
pressor lipid containing a C26 fatty acid in sn-2 position of an inositol
glycerophospholipid.
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FIGURE 2. The SLC1-1 strain grows and is viable in the absence of sphingolipids. A, comparison of growth rates between wild-type (YRS1878) and SLC1-1
lcb1 (YRS1877) suppressor strain in the absence or presence (PHS) of phytosphingosine. Cells were cultivated in complete synthetic liquidmediumat 24 °C,
and optical densitywas recorded over time. B, comparison of colony formation capacity betweenwild-type and SLC1-1 suppressor strain. Cells were cultivated
in complete synthetic liquid medium at 24 °C, and aliquots were removed at the times indicated, diluted, and plated on solid YPD medium. Colonies were
counted after 4 days of incubation at 24 °C. Values given in A and B represent means and S.D. of two independent determinations. C, comparison of inositol-
containing lipids between wild-type and SLC1-1 suppressor strain. Cells were cultivated in the absence or presence of PHS, and lipids were labeled with
[3H]inositol, extracted, and analyzedby TLC.Mild base-resistant sphingolipids are shownon the right half of the chromatogram. Lipids are indicated as follows.
PI, phosphatidylinositol; IPC, inositolphosphorylceramide; lysoPI, lysophosphatidylinositol;MIPC, mannosyl-inositolphosphorylceramide; andM(IP)2C, manno-
syl-diinositolphosphorylceramide.D, analysis of suppressor lipidsbymass spectrometry.Microsomalmembraneswereprepared fromwild typeand the SLC1-1
lcb1 suppressor strain, and lipids were extracted and analyzed by mass spectrometry. Sphingolipids in wild-type cells are IPC-C (m/z 952.7) and MIPC-C (m/z
1114.7). C26 containing glycerophosphoinositol species in SLC1-1 lcb1 are PI 42:1 (m/z 947.6) and PI 44:1 (m/z 975.7). E, suppressor lipids contain a C26:0 fatty
acid. Fragmentation of the suppressor lipids PI 42:1 (m/z 947.6) and PI 44:1 (m/z 975.7) reveals daughter ions of m/z 395.4 corresponding to C26:0. CFU,
colony-forming units.
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tant membrane fraction even in cells lacking sphingolipids but
making suppressor lipids (Fig. 3A). The ER membrane protein
and component of the oligosaccharyltransferase complex,
Wbp1p, on the other hand, was solubilized upon detergent
treatment and stayed in the bottom fractions of the gradient.
Depletion of sphingolipids by using a temperature-sensitive
mutant in long-chain base synthesis, lcb1-100 (end8-1),
impaired the association of Pma1p and Gas1p with detergent-
resistant membranes at the nonpermissive temperature, as has
been observed before (20, 25) (Fig. 3B). These results thus indi-
cate that the function of sphingolipids in the formation of
detergent-resistant membrane domains at the plasma mem-
brane can be substituted by C26-containing inositol gylcero-
phospholipids made in the SLC1-1 suppressor strain. This sub-
stitution, however, appears to be slightly compromised, as
indicated by the fact that the flotation behavior of both Pma1p
and Gas1p when isolated from the SLC1-1 suppressor strain
differs slightly from that of wild-type cells. When isolated from
the suppressor strain, Pma1p and Gas1p displayed a trailing
population of protein that did not exclusively fractionate in the
top fraction, as was the case in wild type. Similarly, the addition
of PHS to wild-type cells induced the appearance of a popula-
tion ofGas1p thatwas detergent-soluble. PHS addition has pre-
viously been shown to induce ubiquitin-dependent internaliza-
tion and down-regulation of the uracil permease Fur4p (26).
Based on this observation, it is conceivable that PHS also
induces down-regulation of Gas1p and that this down-regula-
tion is accompanied by the exclusion of Gas1p from detergent-
resistant membranes.
Suppressor Lipids Functionally Substitute Sphingolipids in
Surface Transport of Newly Synthesized Pma1p—Sphingolipid
synthesis is required for the association of newly synthesized
Pma1p with detergent-resistant membranes already in the ER
and for proper routing of Pma1p to the cell surface (2, 7, 8). In
the absence of sphingolipids, newly synthesized Pma1p is rap-
idly degraded in the vacuole. Given that C26-containing sup-
pressor lipids can substitute for sphingolipids in raft association
of steady-state levels of Pma1p at the plasma membrane, we
examined whether these lipids also protected newly synthe-
sized Pma1p from missorting to the vacuole. Therefore, the
stability of newly synthesized Pma1p in the SLC1-1 suppressor
strain grown in the presence or absence of PHS was examined
by pulse-chase analysis and immunoprecipitation. These
experiments revealed that newly synthesized Pma1p was stable
in the SLC1-1 suppressor strain independent of whether sup-
pressor lipids or sphingolipids were synthesized (Fig. 4A). This
result would thus indicate that suppressor lipids functionally
substitute for sphingolipids also in surface transport of newly
synthesized Pma1p. Moreover, the suppressor lipids appeared
to provide full functionality as indicated by the fact that Pma1p
was stable even when synthesized at 37 °C. The stability of
Pma1p at 37 °C allows for discrimination between fully func-
tional sphingolipids with amature C26 fatty acid and those that
are conditionally impaired in function due to the presence of a
C22 fatty acid, as is the case in acyl chain elongase mutant cells,
elo3 (10, 11, 27).
Given that suppressor lipids can substitute for sphingolipids
in surface transport of Pma1p, one would expect that Pma1p
biogenesis in the suppressor strain becomes resistant against
degradation induced by drugs that inhibit sphingolipid biosyn-
thesis. To test this prediction, we compared the stability of
newly synthesized Pma1p in the SLC1-1 strain with that of
wild-type cells upon treatment with three different inhibi-
tors of the sphingolipid biosynthetic pathway. Myriocin (20
g/ml) was used to block long-chain base synthesis by serine
palmitoyltransferase, fumonisin B1 (72 g/ml) to block cera-
mide synthase, and aureobasidin A (2 g/ml) to inhibit the
conversion of ceramide to inositolphosphorylceramide (28–
30). This analysis revealed that Pma1p was rapidly turned over
in drug-treated wild-type cells but that Pma1p was stable in the
SLC1-1 suppressor strain (Fig. 4B). This observation is thus
consistent with the notion that the C26-containing suppressor
lipids functionally substitute for sphingolipids in surface trans-
port of newly synthesized Pma1p. In addition, these data indi-
FIGURE 3. Steady-state association of Pma1p and Gas1p with detergent-
resistant membranes in the absence of sphingolipids. A, wild type
(YRS1878) and the SLC1-1 lcb1 (YRS1877) suppressor strain were cultivated
at 24 °C in liquid syntheticmedium in the presence or absence of PHS to early
logarithmic growth phase. Membranes were extracted with Triton X-100 and
floated in an Optiprep gradient. Fractions were collected from the top of the
gradient, and proteinswere precipitated by trichloroacetic acid and analyzed
on Western blots probed with antisera against Pma1p, Gas1p, and the ER
membrane protein Wbp1p. B, the association of Pma1p and Gas1p with
detergent-resistant membranes depends on the synthesis of sphingolipids.
lcb1-100 (YRS1029) was cultivated at 24 °C and split, and half of the culture
was shifted to 37 °C for 4 h. Membranes were extracted with detergent, frac-
tionated on an Optiprep gradient, and analyzed by Western blot.
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cate that surface transport of Pma1p is one of the essential
pathways that is blocked by these three inhibitors of the sphin-
golipid pathway in wild-type cells.
To confirm that Pma1p reaches the cell surface in the
absence of sphingolipids rather than stably accumulating
within an intracellular compartment, we examined the steady-
state distribution of a GFP-tagged version of Pma1p by fluores-
cent microscopy. In cells lacking sphingolipids, Pma1p-GFP
displayed a characteristic ringlike staining at the cell periphery,
consistent with surface transport of Pma1p in the absence of
sphingolipids. No fluorescence was observed to accumulate in
the vacuole, even in SLC1-1 cells that were shifted to 37 °C,
indicating that Pma1p is stable at the cell surface in the absence
of sphingolipids (Fig. 5). Drug-induced inhibition of sphingo-
lipid synthesis resulted in vacuolar localization of Pma1p-GFP
in wild-type cells but not in the SLC1-1 suppressor strain (Fig.
5). Taken together, these results indicate that the C26-contain-
ing suppressor lipids that are synthesized in the semidominant
1-acyl-sn-glycerol-3-phosphate acyltransferasemutant SCL1-1
strain fully substitute for sphingolipids in surface transport and
stabilization of Pma1p.
Long-chain Base Synthesis Is Dispensable for Endocytosis in
the Suppressor Strain—Long-chain base synthesis is required
for the internalization step of endocytosis and for the organiza-
tion of the actin cytoskeleton (31). We previously showed that
the accelerated turnover of Pma1p in an elo3mutant at 37 °C
can be rescued by preventing endocytosis, indicating that turn-
over of Pma1p in elo3 occurs after the protein has reached the
cell surface (10). To examine whether the apparent stability of
newly synthesized Pma1p in the suppressor strain was due to a
block in endocytosis in this strain, we examined whether the
suppressor strain was defective in endocytosis. Uptake of the
fluid phasemarker lucifer yellow in the SLC1-1 strain, however,
was comparable with that of wild-type cells, and the fluorescent
dye was rapidly transported to the vacuole, indicating that
endocytosis is functional even in the absence of sphingolipids
(Fig. 6A). A block in de novo sphingolipid biosynthesis using the
conditional lcb1-100 mutant, on the other hand, resulted in a
block in endocytosis in cells incubated at 37 °C, and this block
was rescued by the addition of PHS, consistent with the
reported requirement for long-chain base synthesis in endocy-
tosis in cells that make sphingolipids (31). The long-chain base
requirement for endocytosis can be overcome by overexpres-
sion of protein kinases (YCK2, PKC1, and PKH1/2) or inactiva-
tion of the ceramide-activated PP2A (protein phosphatase 2A)
(32, 33). The fact that the suppressor strain has no block in
endocytosis is interesting and may be explained by the absence
FIGURE 4. Newly synthesized Pma1p is stable and resistant against
sphingolipid-dependent turnover in SLC1-1. A, SLC1-1 lcb1 (YRS1877)
was cultivated in liquid synthetic medium with or without PHS at 24 °C
and shifted to 37 °C for 15 min, and Pma1p stability was examined by
pulse-chase analysis and immunoprecipitation. Levels of Pma1p were
quantified using a PhosphorImager and are shown in the graph. B, biogen-
esis of Pma1p in the suppressor strain is resistant against sphingolipid-de-
pendent degradation. Wild-type (YRS1878) and SLC1-1 lcb1 (YRS1877)
suppressor cells were cultivated at 24 °C; preincubated with either myri-
ocin (20 g/ml), fumonisin B1 (75 g/ml), or aureobasidin A (2 g/ml) for
15min; and then shifted to 37 °C for 15min. Cells were labeled, and Pma1p
turnover was examined by immunoprecipitation. Quantification of
Pma1p levels is shown in the graph. The data shown in A and B represent
means and S.D. of three independent experiments.
FIGURE 5. Steady-state localization of Pma1p to the cell surface in SLC1-1
is resistant against sphingolipid-dependent turnover. Pma1p is located
at the plasma membrane in the absence of sphingolipids. Wild-type
(YRS2569) and SLC1-1 lcb1 (YRS2941) expressing a GFP-tagged version of
Pma1p were cultivated in liquid synthetic medium at 24 °C or shifted to 37 °C
for 2 h in the presence or absence of sphingolipid inhibitors (myriocin (myr)
(20 g/ml), fumonisin B1 (fum) (75 g/ml), and aureobasidin A (Aba) (2
g/ml)), and the subcellular localization of Pma1p was examined by fluores-
cence microscopy. Bar, 5 m.
6
ht
tp
://
do
c.
re
ro
.c
h
of ceramide andhence reducedPP2Aactivity in these cells, thus
allowing endocytosis to proceed in the absence of a long-chain
base.
To confirm that the apparent stability of newly synthesized
Pma1p in the suppressor strain was not due to a defect in PHS-
dependent endocytosis, we examined the stability of Pma1p by
pulse-chase analysis in the presence or absence of PHS, added
at the beginning of the labeling period. Sampleswere then taken
30 or 120min after PHS addition, and Pma1p levels were deter-
mined by immunoprecipitation. If PHSwere required for endo-
cytosis in the SLC1-1 strain, one would predict that its addition
would ultimately result in down-regulation of Pma1p. The
addition of PHS, however, did not affect Pma1p levels in the
suppressor strain (Fig. 6B). This observation is thus consistent
with the notion that the stability of Pma1p in this suppressor
strain is not due to a defect in endocytosis and vacuolar degra-
dation of the protein but reflects
stable delivery of Pma1p to the
plasma membrane in the absence of
sphingolipids.
Suppressor Lipids Functionally
Substitute Sphingolipids in Raft
Association of Newly Synthesized
Pma1p—Newly synthesized Pma1p
rapidly acquires detergent resist-
ance in wild-type cells, and we pre-
viously showed that this is inde-
pendent of ongoing sterol synthesis
but that raft association of Pma1p
depends on the presence of a
mature C26 fatty acid on sphingo-
lipids, because an acyl chain elon-
gase mutant, elo3, conditionally
affects detergent association of
Pma1p at 37 °C (2, 11). To deter-
mine whether suppressor lipids
provided detergent resistance to
newly made Pma1p, we examined
detergent solubility of newly syn-
thesized Pma1p by pulse-chase
analysis and immunoprecipitation.
This type of analysis is performed in
cells that lack the vacuolar protease
Pep4p and hence do not degrade
newlymade Pma1p uponmistarget-
ing to the vacuole (10, 11). Pulse-
chase analysis followed by detergent
extraction revealed that newly syn-
thesized Pma1p acquired detergent
resistance in pep4 mutant cells
that lacked sphingolipids but syn-
thesized suppressor lipids (Fig. 7).
The kinetics with which Pma1p
became detergent-resistant, how-
ever, appeared to be slowed in the
SLC1-1 strain (SLC1-1 lcb1
pep4) compared with wild type
(pep4). This was particularly evi-
dent at 24 °C. Nevertheless, the fact that Pma1p acquired deter-
gent resistance even at 37 °C indicated that suppressor lipids
were functional even under high stringent conditions. Suppres-
sor lipids thus are more functional in supporting biogenesis of
Pma1p than are sphingolipids having a shortened C22 fatty
acid, as made in the acyl chain elongase mutant, elo3.
The Essential Functionality of Suppressor Lipids Depends on
the Presence of the C26 Fatty Acid—Having established the
functionality of suppressor lipids in raft association and stable
surface transport of Pma1p, we next asked whether the func-
tion of these lipids required the presence of thematureC26 acyl
chain or whether a shorter C22 acyl chain would still provide
functionality to these suppressor lipids. Therefore, we gener-
ated a SLC1-1 lcb1 elo3mutant strain in which the suppres-
sor lipids are expected to carry a C22 rather than a C26 fatty
acid. Remarkably, this strain was viable only when supple-
FIGURE 6. A block in endocytosis does not account for the apparent stability of Pma1p in SLC1-1.
A, endocytosis of lucifer yellow in the suppressor strain is not affected by the absence of sphingolipids. Wild-
type (YRS1878), SLC1-1 lcb1 (YRS1877), and lcb1-100 (YRS1029) cells were cultivated in liquid synthetic
medium lackingor containingPHS (PHS; 25M) at 24 °C and shifted to 37 °C for 2h. Cellswere incubatedwith
lucifer yellow (5mg/ml) for 60min at 37 °C and analyzed by fluorescencemicroscopy. Delivery of lucifer yellow
to thevacuole is indicatedbyarrows.Bar, 5m.B, Pma1pstability in SLC1-1 lcb1 is not affectedby theaddition
of PHS. Wild-type and SLC1-1 lcb1were cultivated in liquid synthetic medium at 24 °C, shifted to 37 °C for 2 h,
pulse-labeledat time0 for 15min, andchased for 30and120min in thepresenceor absenceof PHS (25M) that
was added at time 0. Quantification of Pma1p levels is shown in the graphs. The data shown represent means
and S.D. of three independent experiments.
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mented with PHS, indicating that the essential functionality of
suppressor lipids indeed critically depended on the presence of
the mature C26 fatty acid (Fig. 8A). When cultivated in liquid
medium lacking PHS, the strain ceased growth after 12 h of
growth, a time point at which endogenous PHS levels probably
became depleted (Fig. 8B). Analysis of Pma1p stability in this
SLC1-1 lcb1 elo3mutant strain revealed rapid turnover and
delivery of Pma1p to the vacuole at 37 °C, independent of the
presence or absence of PHS (Fig. 8,C andD). These results thus
indicated that the SLC1-1 lcb1 elo3mutant strain displayed
the same conditional turnover of Pma1p as observed in the
elongase, elo3, mutant itself. These observations thus strongly
indicate that the mature C26 fatty acid either bound to a cera-
mide or a glycerophospholipid is critical for stable surface deliv-
ery of Pma1p at 37 °C, consistent with our earlier observations
(10, 11). The C26 acyl chain on suppressor lipids thus is essen-
tial, and one of the essential functions that these very long acyl
chains fulfill is to promote surface transport and stabilization of
the proton-pumping ATPase.
DISCUSSION
The aim of this study was to discriminate between the role of
ceramide/sphingolipids and that of the saturated very long-
chain C26 fatty acid that is present on the yeast ceramide in
promoting raft association and stable surface transport of the
plasma membrane H-ATPase, Pma1p. To discriminate
between the function of ceramide and that of the C26 very
long-chain fatty acid, which under normal conditions (i.e. in
sphingolipid-synthesizing cells) are intimately related,wemade
use of a suppressor strain that synthesizes C26-containing
inositolphospholipids instead of sphingolipids due to the pres-
ence of a semidominant mutation
in a 1-acyl-sn-glycerol-3-phosphate
acyltransferase, SLC1-1 (15).
Characterization of this suppres-
sor strain revealed that the C26-
containing inositolphospholipids
robustly substituted for sphingolip-
ids in all of the aspects tested. (i)
Suppressor lipids substituted for
sphingolipids in raft association of
steady-state levels of Pma1p and
Gas1p at the yeast plasma mem-
brane. (ii) Suppressor lipids enabled
newly synthesized Pma1p to rapidly
acquire detergent resistance. (iii)
They promoted routing of Pma1p to
the cell surface. (iv) They promoted
stabilization at the surface. These
results thus indicate that the C26
fatty acid rather than ceramide or
sphingolipids per se provides the
important function of sphingolipids
in Pma1p biogenesis.
In addition to being functional
in transport and stabilization of
Pma1p, suppressor lipids also allow
the H-ATPase to be enzymatically
active at the plasma membrane, since loss of Pma1p function
would be lethal (34). The efficiency of proton extrusion by the
H-ATPase in the absence of sphingolipids, however, is limit-
ing, as indicated by the fact that cells with suppressor lipids are
unable to grow at lowpH, at 37 °C, or in the presence of high salt
concentrations (34). These environmental stresses are known
to inhibit the growth of strainswith defectiveH-ATPase, indi-
cating that the efficiency of Pma1p in the absence of sphingo-
lipids is compromised. Whether sphingolipids are directly
required for the enzymatic function of Pma1p or whether the
reduced proton extrusion that is observed in the suppressor
strain is due to an impaired proton permeability barrier of a
membrane without sphingolipids, however, remains to be
determined (34).
Consistent with the notion that the C26 fatty acid provides
the important function of sphingolipids in Pma1p biogenesis,
we find that the function of suppressor lipids in Pma1p biogen-
esis and possibly other vital functions critically depends on the
presence of the C26 fatty acid. This is indicated by the fact that
the suppressor strain is not viable in combination with a muta-
tion that results in the synthesis of shorter acyl chains, elo3.
These results thus strongly indicate that the conditional turn-
over of Pma1p observed in elo3mutant cells is due to a struc-
tural role of C26-containing sphingolipids rather than a possi-
ble signaling function of intermediates of the sphingolipid
pathway, such as long-chain base or ceramide. In addition, the
results also indicate that at least one essential function of sphin-
golipids is provided by the ceramide-bound C26 fatty acid (i.e.
the biogenesis of the essential Pma1p).
C26-containing lipids are a hallmark of the yeast plasma
membrane. Synthesis of these lipids, however, occurs in the ER,
FIGURE 7. Newly synthesized Pma1p rapidly acquires detergent resistance in SLC1-1. pep4-deficient
wild-type (YRS2843) and SLC1-1 lcb1 (YRS2138) cells were pulse-labeled at either 24 °C or after a preshift to
37 °C for 15 min. Samples were removed at the indicated time points after the addition of chase and split into
a total (T) fraction and a second fraction that was extracted with 1% Triton X-100 for 30 min on ice. The
detergent fraction was centrifuged at 100,000 g for 1 h to yield a detergent-resistant pellet (P) and a soluble
(S) fraction. Pma1p was immunoprecipitated and analyzed by gel electrophoresis. Quantification of Pma1p
levels in the detergent-resistant pellet as a function of temperature and time is shown in the graphs, in which
the signal intensity obtained in the total fraction (T) was set to 100%, and that of the detergent-resistant pellet
(P) is represented as a black bar. The data shown represent means and S.D. values of three independent
experiments.
8
ht
tp
://
do
c.
re
ro
.c
h
where both the fatty acid elongase and the ceramide synthase
are located (35, 36). Thus, similar to integral membrane pro-
teins that are destined to the cell surface, C26-containing cera-
mide/sphingolipids must travel from the ER to the plasma
membrane. The fact that these lipids affect detergent solubility
of newly synthesized Pma1p already upon ER exit would indi-
cate that lipids and proteins may already assemble at their site
of synthesis and are then cotrans-
ported to the surface (2). A failure to
properly assemble this lipid-protein
complex results either in a diversion
of surface-destined vesicle to the
vacuole, a failure to stabilize the
complex upon arrival at the plasma
membrane, or both (7–10).
Our observations indicate that
C26-containing lipids are essential
for the formation of functional lip-
id-protein complexes. The precise
function that the C26 acyl chain ful-
fills in this assembly, however,
remains to be defined. It has been
suggested that the length of the
transmembrane domain of proteins
along the secretory pathway may
increase to match bilayers of
increasing “thickness” (37). In such
amodel, the abundance ofC26-con-
taining lipids may determine the
thickness of membranes along the
secretory pathway. The evidence
that the yeast plasma membrane is
thicker than other membranes,
however, is mostly based on elec-
tron microscopy and thus suscepti-
ble to possible artifacts based on the
fixation and staining procedures
(38, 39). Biophysical studies with
pure lipid bilayers indicate that lip-
ids with highly asymmetric acyl
chains can interdigitate into the
hydrophobic core of the opposite
half of the bilayer and thus do not
necessarily increase the thickness of
the bilayer (40, 41). Such studies,
however, do not account for the role
of sterols, proteins, and an asym-
metric lipid composition of the two
leaflets of the bilayer on the precise
arrangement of the very long acyl
chains and their effects on the
bilayer. Proteins, for example, have
recently been shown to modulate
bilayer thickness by more than 10%
(42). The thickness of the lipid com-
ponent of a biological membrane
thus must not naturally match that
of the proteins as has been sug-
gested before (43, 44). Based on these considerations, we
believe that it is premature to correlate acyl chain length with
bilayer thickness in biological membranes and that an alterna-
tive function of the C26 acyl chains could be to interdigitate
into the opposite leaflet, thereby (i) coupling the two halves of
the bilayer to lower the energy required to deform this poten-
tially stiff cholesterol-rich membrane and (ii) increasing acyl
FIGURE 8. Suppressor lipids require a C26 fatty acid for functionality. A, viability of a suppressor strain
combined with a mutation in the elongase (ELO3) depends on exogenous PHS. Wild-type (YRS1878) elo3
(YRS1118), SLC1-1 lcb1 (YRS1877), and SLC1-1 lcb1 elo3 (YRS2914) cells were streaked onto solid synthetic
medium containing or lacking PHS (5M). Growth was recorded after 4 days of incubation at 24 °C. B, compar-
ison of growth rates of SLC1-1 lcb1 elo3 (YRS2914) in the absence or presence (PHS) of phytosphingosine.
Cellswere cultivated in complete synthetic liquidmediumat 24 °C, andoptical densitywas recordedover time.
Values represent means and S.D. values of two independent determinations. C, conditional turnover of newly
synthesized Pma1p in a SLC1-1 lcb1 elo3. The suppressor strain lacking ELO3 (YRS2914)was cultivated in the
presence of PHS or shifted tomedium lacking PHS for 6 h and incubated at either 24 or 37 °C for 15min. Pma1p
stability was examined by pulse-chase analysis and immunoprecipitation. Quantification of Pma1p levels is
shown in the graph. The data shown represent means and S.D. of three independent experiments. D, Pma1p-
GFP reaches the vacuole in the suppressor strain lacking ELO3. The suppressor strain lacking ELO3 expressing
Pma1p-GFP (YRS2943)was cultivated in themediumsupplementedwith PHS (5M) at 24 °C. Cellswere shifted
to 37 °C for 2 h and analyzed by fluorescencemicroscopy. Vacuolar staining is indicated by an arrow. Bar, 5m.
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chain packing density to prevent permeability by small mole-
cules, particularly protons.
The ceramide backbone and saturated acyl chain on sphin-
golipids favorably interact with sterols to form condensed com-
plexes that are generally believed to be a driving force for
microdomain formation (14, 45). The fact that the ceramide
backbone on the yeast sphingolipids is dispensable for the func-
tion of sphingolipids in Pma1p biogenesis is in agreement with
our previous observation that Pma1p biogenesis is independent
of the precise sterol structure and even independent of ongoing
sterol synthesis (11). Genetic interactions between mutations
in acyl chain elongation and defects in certain sterol modifica-
tions, on the other hand, indicate that, in vivo, sphingolipid-
sterol interactions are affected by the length of the C26 acyl
chain of sphingolipids (10).
A better understanding of the role that these asymmetrical
C26-containing lipids have on protein sorting to the plasma
membrane is important because elongase mutant cells not
only affect Pma1p stability but also show delayed ER to Golgi
transport of the glycosylphosphatidylinositol-anchored pro-
tein Gas1p and defective surface transport of an artificial
membrane-anchored cargo protein (35, 46). We have previ-
ously characterized the biophysical properties of an inositol
glycerophospholipid with a C26 fatty acid in position sn-1
and shown that this lipid is very potent in lowering the
bilayer to hexagonal transition temperature of liposomes
composed of DEPE (1,2-dielaidoyl-sn-glycero-3-phospho-
ethanolamine) (47). This observation is consistent with the
proposition that this highly asymmetrical lipid could be
important in stabilizing highly curved membrane structures.
Although we currently do not know whether a phosphatidyli-
nositiol with a C26 acyl chain in position sn-2, as made in the
SLC1-1 suppressor strain, or a C26-containing ceramide would
exhibit similar biophysical properties, it is tempting to specu-
late that the effect onmembrane curvature is a general property
of these highly asymmetrical lipids and that one of the essential
functions these lipids may fulfill is to stabilize highly curved
membrane domains that are transiently formed during vesicle
budding and fusion along the secretory pathway (48). Biophys-
ical experiments to compare the properties of such highly
asymmetric lipids will hopefully be instructive to better define
the function of these lipids in vivo.
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